When will Chemist Warehouse shares be trading on the ASX?

A $9 billion monster is being created but when can you invest?

| More on:
Female pharmacist smiles with a digital tablet.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Earlier today, Sigma Healthcare Ltd (ASX: SIG) shares returned from their trading halt with an almighty bang.

Investors were scrambling to buy shares in response to its proposed merger with Chemist Warehouse.

If it completes successfully, this merger will create a ~$9 billion industry behemoth with earnings before interest and tax of $495 million.

Unsurprisingly, investors may now be wondering when they will be able to buy Chemist Warehouse shares. Well, let's take a look and find out.

When will Chemist Warehouse shares be trading on the ASX?

Firstly, you don't technically have to wait for Chemist Warehouse shares to arrive on the ASX boards if you want them in your portfolio.

That's because if the merger with Sigma Healthcare goes ahead, the Amcal owner's shares will become the shares of the merged entity, which is currently known as MergeCo.

Therefore, anyone owning Sigma shares today will own a slice of MergeCo if shareholders and regulators approve the transaction.

But when might that happen?

While the Sigma share price reaction today appears to indicate that the market is both happy with the merger plan and believes it will complete successfully, there's still a bit of work to be done before then.

Sigma's management notes that the proposed merger is expected to complete in the second half of calendar year 2024 if all goes to plan. But it could be worth the wait according to them.

Chemist Warehouse's chair, Jack Gance, believes the merger is the start of another big chapter. He said:

The combination of CWG's retailing and marketing capabilities and Sigma's state-of-the-art distribution infrastructure and logistics capabilities presents a unique opportunity for both CWG and Sigma shareholders. We look forward to building the next chapter of CWG's success for the benefit of our customers, staff, franchisees and shareholders.

This view was echoed by Sigma's chair, Michael Sammells. He adds:

The Proposed Merger is a step-change event for Sigma. With Sigma having had a commercial relationship with CWG and its founders spanning more than 40 years, we are excited by the efficiencies, synergies and growth opportunities that we anticipate being unlocked through the merger of the two complementary businesses. The combined group will have extensive capabilities and expertise to benefit franchisees and customers, including through more brand choice, products and services and expanded marketing capabilities.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX 200 stock is jumping 11% today

Let's see why investors are bidding this stock higher on Wednesday.

Read more »

stockmarket graphic in background with man looking at stockmarket on phone
Healthcare Shares

CSL shares are a buy – UBS

This expert is optimistic on what the business can achieve despite headwinds.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »